Abstract |
There are a number of neurologically active ion channel blocking peptides derived from cone snail venom, such as conantokin-G and omega-conotoxin MVIIA. Conantokin-G inhibits NMDA receptors containing the NR2B subunit whereas omega-conotoxin MVIIA blocks N-type Ca(2+) channels. Separately, these peptides induce antinociceptive effects in pre-clinical pain models following intrathecal injection. In the current study, the efficacies of these peptides were determined separately and in combination by intrathecal injection into rats with a spinal nerve ligation, in rats with a spinal cord compression injury and in the formalin test. Separately, both conantokin-G and omega-conotoxin MVIIA dose-dependently attenuated nociceptive responses in all of these models. However, at high antinociceptive doses for both formalin and nerve injury models, omega-conotoxin MVIIA evoked untoward side effects. Using isobolographic analysis, the combination of sub-antinociceptive doses of peptides demonstrated additive antinociception in rats with a nerve ligation and in the formalin test, without apparent adverse side effects. In a model of neuropathic spinal cord injury pain, which is clinically difficult to treat, the combination of conantokin-G and omega-conotoxin MVIIA resulted in robust synergistic antinociception. These data suggest that a combination of these peptides may be analgesic across diverse clinical pains with limited untoward side effects, and particularly potent for reducing spinal cord injury pain.
|
Authors | Aldric Hama, Jacqueline Sagen |
Journal | Neuropharmacology
(Neuropharmacology)
Vol. 56
Issue 2
Pg. 556-63
(Feb 2009)
ISSN: 0028-3908 [Print] England |
PMID | 19010337
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics
- Conotoxins
- omega-Conotoxins
- ziconotide
- conotoxin GV
|
Topics |
- Analgesics
(therapeutic use)
- Animals
- Conotoxins
(therapeutic use)
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Synergism
- Hyperalgesia
(drug therapy)
- Male
- Motor Activity
(drug effects)
- Neuralgia
(drug therapy)
- Pain Measurement
- Pain Threshold
(drug effects)
- Rats
- Rats, Sprague-Dawley
- Reaction Time
(drug effects)
- Rotarod Performance Test
- Time Factors
- omega-Conotoxins
(therapeutic use)
|